FROG files Form 144 to sell 77,500 shares

FROG filed a Form 144 notifying the sale of 77,500 shares of Common Stock.

Rhea-AI Filing Summary

FROG filed a Form 144 notifying the sale of 77,500 shares of Common Stock. The filing lists multiple 10b5-1 sales by Frederic Simon totaling numerous transactions in early 2026, including a 55,000-share sale on 04/01/2026.

The notice documents prior sales on specific dates and dollar amounts; timing and method reflect planned 10b5-1 dispositions referenced in the excerpt.

Insights

Corporate Governance Specialist

Form 144 lists affiliated selling activity under a 10b5-1 plan.

The filing shows an affiliate intends to sell 77,500 shares and cites multiple recent 10b5-1 transactions by Frederic Simon, including a 55,000-share sale on 04/01/2026. This is a routine disclosure required for affiliate sales.

Impact on capital structure is procedural; magnitude and timing depend on execution. Future filings will show completed dispositions and post-sale holdings if required.

Key Figures

Registered shares: 77,500 shares Recent 10b5-1 sale (example): 55,000 shares Recent 10b5-1 sale (March 26): 9,600 shares +2 more

5 metrics

Registered shares 77,500 shares Securities To Be Sold (Form 144)

Recent 10b5-1 sale (example) 55,000 shares Sale date <date>04/01/2026</date>, proceeds $2,658,862.50

Recent 10b5-1 sale (March 26) 9,600 shares Sale date <date>03/26/2026</date>, proceeds $462,386.88

Recent 10b5-1 sale (Feb 12) 67,500 shares Sale date <date>02/12/2026</date>, proceeds $3,590,541.00

Form type Form 144 notice Rule filing for proposed affiliate sales

Key Terms

Form 144, 10b5-1, Founders Shares

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for FREDERIC SIMON ... Common | 04/01/2026"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Founders Shares market

"Common | 11/16/2013 | Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does FROG's Form 144 report mean?

It notifies a planned sale of 77,500 shares of Common Stock by an affiliate. The form documents proposed dispositions and recent 10b5-1 sales by Frederic Simon in early 2026, supplying transaction dates and dollar amounts for regulatory transparency.

Who executed the recent 10b5-1 sales listed in the Form 144 for FROG?

The excerpt shows multiple 10b5-1 sales by Frederic Simon. Transactions include a 55,000-share sale on 04/01/2026 and other sales in March and February 2026 with disclosed share counts and proceeds.

Does the Form 144 state how the proceeds will be used for FROG?

The filing excerpt documents share counts and dollar amounts for affiliate sales but does not state any use of proceeds. Form 144s typically disclose proposed sales by affiliates rather than company use of funds.

Are the listed sales in FROG's Form 144 open-market trades or planned trades?

The excerpt identifies the transactions as 10b5-1 sales, indicating they were executed under a pre-arranged trading plan. Specific execution methods beyond the 10b5-1 designation are not detailed in the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:25 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001823308
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	JFrog Ltd.
SEC File Number	001-39492
Address of Issuer	270 E. Caribbean Drive Sunnyvale CALIFORNIA 94089
Phone	(408)329-1540
Name of Person for Whose Account the Securities are To Be Sold	FREDERIC SIMON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	77500	3755650.00	119628931	04/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/16/2013	Founders Shares	Issuer			77500	11/16/2013	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for FREDERIC SIMON 270 E. Caribbean Drive Sunnyvale CA 94089	Common	04/01/2026	55000	2658862.50
10b5-1 Sales for FREDERIC SIMON 270 E. Caribbean Drive Sunnyvale CA 94089	Common	03/26/2026	9600	462386.88
10b5-1 Sales for FREDERIC SIMON 270 E. Caribbean Drive Sunnyvale CA 94089	Common	03/25/2026	10400	479394.00
10b5-1 Sales for FREDERIC SIMON 270 E. Caribbean Drive Sunnyvale CA 94089	Common	03/03/2026	10000	420828.00
10b5-1 Sales for FREDERIC SIMON 270 E. Caribbean Drive Sunnyvale CA 94089	Common	03/02/2026	25000	1004587.50
10b5-1 Sales for FREDERIC SIMON 270 E. Caribbean Drive Sunnyvale CA 94089	Common	02/12/2026	67500	3590541.00

144: Remarks and Signature

Remarks
Date of Notice	04/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Frederic Simon
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)